Table of Contents Author Guidelines Submit a Manuscript
Bioinorganic Chemistry and Applications
Volume 2006, Article ID 71938, 7 pages
http://dx.doi.org/10.1155/BCA/2006/71938

Antihuman Immunodeficiency Virus Type 1 (HIV-1) Activity of Rare Earth Metal Complexes of 4-Hydroxycoumarins in Cell Culture

1Department of Organic Chemistry, Faculty of Pharmacy, Medical University, 2 Dunav Street, Sofia 1000, Bulgaria
2Department of Virology, National Center of Infectious and Parasitic Diseases, 44A Stoletov Street, Sofia 1233, Bulgaria
3Laboratory of Molecular Pathology, Medical University, 2 Zdrave Street, Sofia 1606, Bulgaria

Received 23 December 2004; Revised 9 March 2005; Accepted 17 June 2005

Copyright © 2006 Ilia Manolov et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P Zhou, Y Takaishi, H Duan et al., “Coumarins and bicoumarin from Ferula sumbul: anti-HIV activity and inhibition of cytokine release,” Phytochemistry, vol. 53, no. 6, pp. 689–697, 2000. View at Publisher · View at Google Scholar
  2. I Kostova, S Raleva, P Genova, and R Argirova, “Recent advances in the discovery and development of plant-derived natural coumarins and their analogues as anti human immunodeficiency virus–type 1 (HIV-1) agents,” Biotechnology and Biotechnological Equipment, vol. 19, no. 1, pp. 16–22, 2005. View at Google Scholar
  3. X Shao, D HL Ekstrand, R Bhikhabhai, C FR Kallander, and J S Gronowitz, “A non-radioactive microtiter plate reverse transcriptase (RT) assay, based on immobilized template, for screening of RT activity inhibitors and evaluation of their mofe of action,” Antiviral Chemistry & Chemotherapy, vol. 8, no. 2, pp. 149–159, 1997. View at Google Scholar
  4. S Thaisrivongs, K D Watenpaugh, W J Howe et al., “Structure-based design of novel HIV protease inhibitors: carboxamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent nonpeptidic inhibitors,” Journal of Medicinal Chemistry, vol. 38, no. 18, pp. 3624–3637, 1995. View at Publisher · View at Google Scholar
  5. C Spino, M Dodier, and S Sotheeswaran, “Anti-HIV coumarins from Calophyllum seed oil,” Bioorganic & Medicinal Chemistry Letters, vol. 8, no. 24, pp. 3475–3478, 1998. View at Google Scholar
  6. Z Q Xu, E R Kern, L Westbrook et al., “Plant-derived and semi-synthetic calanolide compounds with in vitro activity against both human immunodeficiency virus type 1 and human cytomegalovirus,” Antiviral Chemistry & Chemotherapy, vol. 11, no. 1, pp. 23–29, 2000. View at Google Scholar
  7. Y Kashman, K R Gustafson, R W Fuller et al., “The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum,” Journal of Medicinal Chemistry, vol. 35, no. 15, pp. 2735–2743, 1992. View at Publisher · View at Google Scholar
  8. A Mazumder, S Wang, N Neamati et al., “Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease,” Journal of Medicinal Chemistry, vol. 39, no. 13, pp. 2472–2481, 1996. View at Publisher · View at Google Scholar
  9. F Rosskopf, J Kraus, and G Franz, “Immunological and antitumor effects of coumarin and some derivatives,” Die Pharmazie, vol. 47, no. 2, pp. 139–142, 1992. View at Google Scholar
  10. P McCulloch and W D George, “Warfarin inhibits metastasis of Mtln3 rat mammary carcinoma without affecting primary tumour growth,” British Journal of Cancer, vol. 59, no. 2, pp. 179–183, 1989. View at Google Scholar
  11. I Kostova, I Manolov, S Konstantinov, and M Karaivanova, “Synthesis, physicochemical characterisation and cytotoxic screening of new complexes of cerium, lanthanum and neodymium with Warfarin and Coumachlor sodium salts,” European Journal of Medicinal Chemistry, vol. 34, no. 1, pp. 63–68, 1999. View at Publisher · View at Google Scholar
  12. I P Kostova, I I Manolov, I N Nicolova, and N D Danchev, “New metal complexes of 4-methyl-7-hydroxycoumarin sodium salt and their pharmacological activity,” Il Farmaco, vol. 56, no. 9, pp. 707–713, 2001. View at Publisher · View at Google Scholar
  13. I Kostova, I Manolov, I Nicolova, S Konstantinov, and M Karaivanova, “New lanthanide complexes of 4-methyl-7-hydroxycoumarin and their pharmacological activity,” European Journal of Medicinal Chemistry, vol. 36, no. 4, pp. 339–347, 2001. View at Publisher · View at Google Scholar
  14. I Manolov, I Kostova, S Konstantinov, and M Karaivanova, “Synthesis, physicochemical characterization and cytotoxic screening of new complexes of cerium, lanthanum and neodymium with Niffcoumar sodium salt,” European Journal of Medicinal Chemistry, vol. 34, no. 10, pp. 853–858, 1999. View at Publisher · View at Google Scholar
  15. I Manolov, I Kostova, T Netzeva, S Konstantinov, and M Karaivanova, “Cytotoxic activity of cerium complexes with coumarin derivatives. Molecular modeling of the ligands,” Archiv der Pharmazie: Pharmaceutical and Medicinal Chemistry, vol. 333, no. 4, pp. 93–98, 2000. View at Publisher · View at Google Scholar
  16. D C Montefiori, W E Jr Robinson, S S Schuffman, and W M Mitchell, “Evaluation of antiviral drugs and neutralizing antibodies to human immunodeficiency virus by a rapid and sensitive microtiter infection assay,” Journal of Clinical Microbiology, vol. 26, no. 2, pp. 231–235, 1988. View at Google Scholar
  17. J A Zack, S J Arrigo, S R Weitsman, A S Go, A Haislip, and I S Chen, “HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure,” Cell, vol. 61, no. 2, pp. 213–222, 1990. View at Publisher · View at Google Scholar
  18. D J Hazuda, P Felock, M Witmer et al., “Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells,” Science, vol. 287, no. 5453, pp. 646–650, 2000. View at Publisher · View at Google Scholar